Woodline Partners LP Viking Therapeutics, Inc. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 93,294 shares of VKTX stock, worth $2.23 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
93,294
Previous 63,819
46.19%
Holding current value
$2.23 Million
Previous $4.04 Million
7.08%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
466Shares Held
65.8MCall Options Held
5.8MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$244 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$144 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$118 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$62.1 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$51.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.84B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...